75 related articles for article (PubMed ID: 744578)
1. Glucagon responses to secretion and CCK-PZ in diabetes and chronic pancreatitis.
Kalk WJ; Vinik AI; Jackson WP
Horm Metab Res; 1978 Nov; 10(6):562. PubMed ID: 744578
[No Abstract] [Full Text] [Related]
2. Insulin responses to crude cholecystokinin-pancreozymin in normal subjects, in patients with chronic pancreatitis and patients with mild maturity onset diabetes.
Kalk WJ; Vinik AI; Botha JL; Keller P; Jackson WP
J Clin Endocrinol Metab; 1975 Jul; 41(1):172-6. PubMed ID: 1150859
[TBL] [Abstract][Full Text] [Related]
3. Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes.
Hiroyoshi M; Tateishi K; Yasunami Y; Maeshiro K; Ono J; Matsuoka Y; Ikeda S
Am J Gastroenterol; 1999 Apr; 94(4):976-81. PubMed ID: 10201468
[TBL] [Abstract][Full Text] [Related]
4. [Diabetes mellitus in patients with chronic alcoholic pancreatitis].
Sadokov VM; Vinokurova LV
Ter Arkh; 1993; 65(10):27-9. PubMed ID: 8296228
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of alanine-stimulated glucagon secretion by secretin in the dog.
Santeusanio F; Faloona GR; Unger RH
Horm Metab Res; 1973 Nov; 5(6):425-7. PubMed ID: 4766996
[No Abstract] [Full Text] [Related]
6. Effect of the gastrointestinal hormones, secretin and cholecystokinin-pancreozymin, on insulin and glucagon release in healthy and diabetic subjects.
Raptis S; Schröder KE; Rothenbuchner G; Pfeiffer EF
Isr J Med Sci; 1972 Jun; 8(6):769. PubMed ID: 4559420
[No Abstract] [Full Text] [Related]
7. Inhibition of gastric secretion by combined secretin and CCK and combined glucagon and CCK.
Hendel L; Henriksen FW
Scand J Gastroenterol Suppl; 1976; 42():37-9. PubMed ID: 1070793
[No Abstract] [Full Text] [Related]
8. [Diabetes mellitus in acute and chronic pancreatitis (author's transl)].
Strohmeyer G; Gottesbüren H; Behr C
Dtsch Med Wochenschr; 1974 Jul; 99(28):1481-8. PubMed ID: 4605614
[No Abstract] [Full Text] [Related]
9. [Effect of secretin intramuscularly injected on pancreatic polypeptide, insulin and glucagon in diabetic patients (author's transl)].
Toyota T; Koizumi K; Kai K; Umezu M; Miura M
Horumon To Rinsho; 1979; 27(12):1395-8. PubMed ID: 397015
[No Abstract] [Full Text] [Related]
10. Recent research developments in diabetes mellitus. IV.
Sharkey TP
J Am Diet Assoc; 1968 Feb; 52(2):108-17. PubMed ID: 4866012
[No Abstract] [Full Text] [Related]
11. Plasma glucagon response to blood glucose fall, gastrointestinal hormones and arginine in man.
Oneda A; Sato M; Matsuda K; Yanbe A; Maruhama Y
Tohoku J Exp Med; 1972 Jul; 107(3):241-51. PubMed ID: 4639665
[No Abstract] [Full Text] [Related]
12. Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin).
Domschke S; Bloom SR; Adrian TE; Lux G; Domschke W
Hepatogastroenterology; 1988 Oct; 35(5):229-37. PubMed ID: 2465985
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus secondary to chronic pancreatitis.
Larsen S
Dan Med Bull; 1993 Apr; 40(2):153-62. PubMed ID: 8495594
[TBL] [Abstract][Full Text] [Related]
14. [Clinical studies of gastrointestinal hormones and pancreatic function].
Ohara H
Horumon To Rinsho; 1976; 24(2):113-20. PubMed ID: 943245
[No Abstract] [Full Text] [Related]
15. Secretion of labelled proteins by the isolated dog pancreas in the response to secretin and cholecystokinin.
Laval J; Frexinos J; Laval JP; Ribet A
Biomedicine; 1977 Feb; 26(1):65-70. PubMed ID: 861347
[TBL] [Abstract][Full Text] [Related]
16. Lack of accuracy of plasma alpha-amino nitrogen profiles as an indicator of exocrine pancreatic function both after continuous and bolus stimulation of the pancreas with secretin and cholecystokinin-pancreozymin.
Lembcke B; Konle O; Duan LP; Caspary WF
Z Gastroenterol; 1994 Dec; 32(12):679-83. PubMed ID: 7871858
[TBL] [Abstract][Full Text] [Related]
17. Comparison of different endocrine stimulation tests in nondiabetic patients with chronic pancreatitis.
von Tirpitz C; Glasbrenner B; Mayer D; Malfertheiner P; Adler G
Hepatogastroenterology; 1998; 45(22):1111-6. PubMed ID: 9756016
[TBL] [Abstract][Full Text] [Related]
18. [Plasma insulin in chronic pancreatitis].
Azerad E; Bernier JJ; Lubetzki J; Duprey J; Friedler D; Croisier JC
Diabete; 1967; 15(4):269-74. PubMed ID: 5634172
[No Abstract] [Full Text] [Related]
19. Effect of glucagon on pure human exocrine pancretic secretion.
Fontana G; Costa PL; Tessari R; Labo G
Am J Gastroenterol; 1975 Jun; 63(6):490-4. PubMed ID: 1146806
[TBL] [Abstract][Full Text] [Related]
20. [The indices of pancreatic incretory activity in patients with chronic pancreatitis and disordered carbohydrate metabolism].
Geller LI; Pashko MM; Obukhova GG
Vrach Delo; 1990 Nov; (11):77-9. PubMed ID: 2098992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]